All In MedTech

Device Trial Radar · NCT07240649

Emerging Indications for Hyperbaric Oxygen Treatment

Last checked: Nov 19, 2026Latest source record: Sep 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

100

Planned (sponsor's estimate)

Start

Nov 2026

Primary completion

Dec 2035

Study completion Dec 2035

Sponsor

Lead sponsor
Jay C. Buckey Jr.Academic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Dartmouth College
First posted
Nov 21, 2025

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will evaluate the effectiveness of hyperbaric oxygen therapy (HBOT) on treating emerging indications (i.e., conditions that have shown to potentially benefit from HBOT) using the Multicenter Registry for Hyperbaric Oxygen Treatment. The study team aims to collect ongoing data on how well HBOT treats these emerging indications, and to add these data to the growing HBO Registry. The research team hypothesizes that HBOT will result in improvements of the condition of the various emerging indications.

Conditions

  • Post-COVID-19 Condition
  • Ulcerative Colitis
  • Crohn Disease
  • Calciphylaxis
  • Frostbite
  • Acute COVID-19
  • Pyoderma Gangrenosum
  • Pterygium
  • Hypospadias
  • Head Trauma
  • Pneumatosis Intestinalis
  • Ischemic Bowel
  • Raynaud Syndrome
  • Malignant Otitis Externa
  • Nonarteritic Anterior Ischemic Optic Neuropathy
  • Central Retinal Vein Occlusion
  • Femoral Head Necrosis
  • Invasive Fungal Infection
  • Chronic Anal Fissure
  • Vasculitic Ulcer
  • Graft-vs-Host Disease
  • Decubitus Ulcer
  • Greater Trochanteric Pain Syndrome
  • Rectovaginal Fistula
  • Pouchitis
  • Tinnitus
  • Clostridium Enterocolitis
  • Branch Retinal Artery Occlusion
  • Axonotmesis
  • Multiple Sclerosis
  • Inclusion Body Myositis
  • Epidermolysis Bullosa (EB)
  • Osteonecrosis
  • Ulcer Ischemic
  • Avascular Necrosis of Bone
  • Prosthesis Related Infections
  • Facial Filler Injections
  • Cystitis Chronic
  • Ligament Injury
  • Anastomosis, Leaking
  • Cartilage Injury

Interventions

  • Hyperbaric oxygen treatment (HBOT)Device

    Hyperbaric oxygen refers to oxygen given at pressures higher than atmospheric pressure (higher than 1.4 ATA) in pressurized chamber.

  • 100% OxygenDrug

    Receiving 100% oxygen as part of HBOT

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Quality of Life EuroQOL EQ-5D-5L QuestionnaireTime frame: Within one week of starting HBO2 and within one week of ending HBO2 treatment

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.